Ziqi Cheng
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Global burden and trends of primary liver cancer are attributable to high BMI among hepatitis B patients: based on the 2021 global burden of disease study.
Journal: International journal of surgery (London, England)
Published: June 30, 2025
TRIM47-CDO1 axis dictates hepatocellular carcinoma progression by modulating ferroptotic cell death through the ubiquitin‒proteasome system.
Journal: Free radical biology & medicine
Published: March 11, 2024
Dihydroartemisinin induces ferroptosis of hepatocellular carcinoma via inhibiting ATF4-xCT pathway.
Journal: Journal of cellular and molecular medicine
Published: September 28, 2023
Promotion of colorectal cancer cell death by ezetimibe via mTOR signaling-dependent mitochondrial dysfunction.
Journal: Frontiers in pharmacology
Published: October 27, 2022
Targeting fatty acid synthase modulates sensitivity of hepatocellular carcinoma to sorafenib via ferroptosis.
Journal: Journal of experimental & clinical cancer research : CR
Published: October 09, 2022
Cordycepin Protects against Hepatic Ischemia/Reperfusion Injury via Inhibiting MAPK/NF-κB Pathway.
Journal: Mediators of inflammation
Published: April 08, 2022
Luteolin Pretreatment Attenuates Hepatic Ischemia-Reperfusion Injury in Mice by Inhibiting Inflammation, Autophagy, and Apoptosis via the ERK/PPARα Pathway.
Journal: PPAR research
Published: January 18, 2022
Sodium butyrate inhibits aerobic glycolysis of hepatocellular carcinoma cells via the c-myc/hexokinase 2 pathway.
Journal: Journal of cellular and molecular medicine
Published: December 07, 2021
Pemafibrate Pretreatment Attenuates Apoptosis and Autophagy during Hepatic Ischemia-Reperfusion Injury by Modulating JAK2/STAT3β/PPARα Pathway.
Journal: PPAR research
Published: November 06, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026